SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

Theravance Biopharma Q1 EPS $(1.400) Misses $(1.070) Estimate, Sales $19.900M Beat $18.130M Estimate

Theravance Biopharma (NASDAQ:TBPH) reported quarterly losses of $(1.400) per share which missed the analyst consensus estimate of $(1.070) by 30.84 percent. This is a 6.06 percent decrease over losses of $(1.320) per

Benzinga · 05/06/2020 20:28

Theravance Biopharma (NASDAQ:TBPH) reported quarterly losses of $(1.400) per share which missed the analyst consensus estimate of $(1.070) by 30.84 percent. This is a 6.06 percent decrease over losses of $(1.320) per share from the same period last year. The company reported quarterly sales of $19.900 million which beat the analyst consensus estimate of $18.130 million by 9.76 percent. This is a 272.80 percent increase over sales of $5.338 million the same period last year.